Loading...
•
Sep 30, 2025
Mimedx Q3 2025 Earnings Report
Mimedx reported record revenue and strong profitability for the third quarter of 2025, driven by double-digit growth in both Wound and Surgical franchises.
Key Takeaways
Mimedx achieved record net sales of $114 million in Q3 2025, a 35% increase year-over-year, with significant growth in both its Wound and Surgical product categories. The company also reported strong GAAP net income of $17 million and adjusted EBITDA of $35 million, representing a 31% margin, and raised its full-year 2025 net sales growth and adjusted EBITDA expectations.
Mimedx reported record net sales of $114 million for Q3 2025, marking a 35% increase compared to the prior year.
Both Wound and Surgical product categories demonstrated strong growth, with Wound sales increasing by 40% and Surgical sales by 26% year-over-year.
GAAP net income for the quarter was $17 million, and diluted EPS was $0.11, significantly up from $8 million and $0.05 respectively in Q3 2024.
Adjusted EBITDA reached $35 million, or 31% of net sales, reflecting improved operational efficiencies and profitability.
Revenue by Segment
Forward Guidance
Mimedx has raised its full-year 2025 net sales growth expectations to the mid-to-high teens and anticipates an Adjusted EBITDA margin of at least the mid-20% range. The company maintains a long-term outlook of low double-digit annual net sales growth and an Adjusted EBITDA margin above 20%.
Positive Outlook
- Raised 2025 net sales growth expectations to mid-to-high teens percentage.
- Anticipates 2025 Adjusted EBITDA margin to be at least in the mid-20% range.
- Long-term expectation of annual net sales growth in the low double-digits.
- Long-term expectation of Adjusted EBITDA margin above 20%.
- Believes CMS reimbursement reforms will have a stabilizing effect on the industry and be a net positive for Mimedx.
Challenges Ahead
- Future sales are uncertain and affected by competition and market access.
- Company plans may change due to unforeseen circumstances.
- Results of scientific research are uncertain and may have little or no value.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...